デフォルト表紙
市場調査レポート
商品コード
1463049

セントラルラボ市場、シェア、規模、動向、産業分析レポート：サービス別、最終用途別、地域別、セグメント動向、2024年～2032年

Central Lab Market Share, Size, Trends, Industry Analysis Report, By Service, By End-use (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes), By Region, And Segment Forecasts, 2024 - 2032

出版日
ページ情報
英文 115 Pages
納期
即日から翌営業日
カスタマイズ可能
セントラルラボ市場、シェア、規模、動向、産業分析レポート：サービス別、最終用途別、地域別、セグメント動向、2024年～2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界のセントラルラボ市場規模は2032年までに55億5,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

臨床試験業界におけるセントラルラボ業務のアウトソーシング動向は増加傾向にあり、セントラルラボに有利なビジネスチャンスをもたらしています。セントラルラボ業務の約80%は治験責任医師やスポンサーによって外部委託されており、包括的な統合サービスを提供するラボが選好されています。研究開発（R&D）への投資の急増は、特にパンデミック（世界的大流行）時の製薬業界への注目の高まりによって顕著です。

パンデミックから3年目を迎え、科学への投資の高まりはパイプラインを充実させ、多くの臨床試験の開始につながった。パンデミックを通じて、介入試験に関する活動は着実に増加しています。製薬業界は、パンデミック中に進行中の臨床研究を効果的に管理するため、試験の新しい実施方法に適応してきました。

特に新興国市場で顕著な動向である中小規模の中央研究所の出現により、市場の競争は世界的に過熱しています。さらに、新興経済諸国における臨床試験実施の費用対効果から、これらの地域のセントラルラボはより魅力的であり、より低い物流コストと試験実施場所への近さがその魅力に貢献しています。

パンデミックは、特にmRNAワクチンの開発やCOVID-19に対する様々な治療法の検討に重点を置くことで、新たな成長機会をもたらしています。しかし、サンプルの効果的な取り扱いは、サプライチェーンやロジスティクスの管理とともに、臨床検査機関に送られるサンプルという文脈では極めて重要です。COVID-19の検査や研究に関連することが多いこれらのサンプルは、非常にデリケートです。迅速で効率的なロジスティクスの確保は、特に温度管理対策の実施に不可欠です。検査室での分析で正確で信頼できる結果を得るためには、輸送中もこれらのサンプルの安定性を維持することが重要です。サンプルの取り扱いとロジスティクスの複雑さは、パンデミックに関連する研究と診断の取り組みをサポートする、組織化された迅速なシステムの重要性を強調しています。

中央研究所市場レポートハイライト

遺伝子サービス分野は、遺伝子の遺伝事例の増加や多くの臨床研究での使用により急成長します。

主に臨床試験数の増加により、製薬会社が最大のシェアを占める

新興経済諸国における個別化治療の増加により北米が市場を独占

主な市場プレイヤーは、ACM Global Laboratories、Labconnect、Cerba Research、Medicover Integrated Clinical Services、Versiti、Cirion Biopharmaなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界セントラルラボ市場の洞察

  • セントラルラボ市場- 業界スナップショット
  • セントラルラボの市場力学
    • 促進要因と機会
      • 臨床試験の増加
      • 慢性疾患の蔓延
    • 抑制要因と課題
      • セントラルラボサービスの高コスト
  • PESTLE分析
  • セントラルラボ業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 サービス別の世界市場

  • 主な調査結果
  • イントロダクション
  • 遺伝子サービス
  • バイオマーカーサービス
  • サービス 3微生物学サービス
  • 解剖病理学/組織学
  • 標本管理と保管
  • 特殊化学サービス
  • その他

第6章 最終用途別の世界市場

  • 主な調査結果
  • イントロダクション
  • 製薬会社
  • バイオテクノロジー企業
  • 学術研究機関

第7章 地域別の世界市場

  • 主な調査結果
  • イントロダクション
    • セントラルラボ市場評価、地域別、2019-2032年
  • セントラルラボ市場-北米
    • 北米：セントラルラボ市場、最終用途別、2019年～2032年
    • 北米：セントラルラボ市場、サービス別、2019-2032年
    • セントラルラボ市場-米国
    • セントラルラボ市場-カナダ
  • セントラルラボ市場- 欧州
    • 欧州：セントラルラボ市場、最終用途別、2019年～2032年
    • 欧州：セントラルラボ市場、サービス別、2019-2032年
    • セントラルラボ市場-英国
    • セントラルラボ市場-フランス
    • セントラルラボ市場-ドイツ
    • セントラルラボ市場-イタリア
    • セントラルラボ市場-スペイン
    • セントラルラボ市場-オランダ
    • セントラルラボ市場-ロシア
  • セントラルラボ市場- アジア太平洋
    • アジア太平洋：セントラルラボ市場、最終用途別、2019年～2032年
    • アジア太平洋：セントラルラボ市場、サービス別、2019-2032年
    • セントラルラボ市場- 中国
    • セントラルラボ市場-インド
    • セントラルラボ市場-マレーシア
    • セントラルラボ市場-日本
    • セントラルラボ市場-インドネシア
    • セントラルラボ市場-韓国
  • セントラルラボ市場-中東およびアフリカ
    • 中東およびアフリカ：セントラルラボ市場、最終用途別、2019-2032年
    • 中東およびアフリカ：セントラルラボ市場、サービス別、2019-2032年
    • セントラルラボ市場-サウジアラビア
    • セントラルラボ市場-UAE
    • セントラルラボ市場-イスラエル
    • セントラルラボ市場-南アフリカ
  • セントラルラボ市場-ラテンアメリカ
    • ラテンアメリカ：セントラルラボ市場、最終用途別、2019-2032年
    • ラテンアメリカ：セントラルラボ市場、サービス別、2019-2032年
    • セントラルラボ市場-メキシコ
    • セントラルラボ市場-ブラジル
    • セントラルラボ市場-アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/公開

第9章 企業プロファイル

  • ACM Global Laboratories
  • Labconnect
  • Cerba Research
  • Eurofins Scientific
  • Medicover Integrated Clinical Services（MICS）（Synevo Central Labs）
  • Versiti（Cenetron）
  • A.P. Moller Holding A/S（Unilabs）
  • Ampersand Capital Partners（Pacific Biomarkers）
  • Lambda Therapeutics Research Ltd
  • Cirion Biopharma Research Inc.
図表

List of Tables

  • Table 1 Global Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 2 Global Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 3 Central Lab Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 5 North America: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 6 U.S.: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 8 Canada: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 10 Europe: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 12 UK: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 13 UK: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 14 France: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 15 France: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 16 Germany: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 18 Italy: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 20 Spain: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 24 Russia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 28 China: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 China: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 30 India: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 31 India: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 34 Japan: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 38 South Korea: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 44 UAE: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 46 Israel: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 48 South Africa: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 50 Latin America: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 52 Mexico: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 54 Brazil: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • Table 56 Argentina: Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Central Lab Market, by Services, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Central Lab Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Central Lab Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Services
  • Figure 9 Global Central Lab Market, by Services, 2022 & 2032 (USD Billion)
  • Figure 10 Central Lab Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Central Lab Market
目次
Product Code: PM4419

The global central lab market size is expected to reach USD 5.55 billion by 2032, according to a new study by Polaris Market Research. The report "Central Lab Market Share, Size, Trends, Industry Analysis Report, By Service, By End-use (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The trend of outsourcing central lab work in the clinical trial industry has been on the rise, presenting lucrative business opportunities for central labs. Approximately 80% of central lab work is outsourced by investigators and sponsors, with a preference for labs offering comprehensive integrated services. The surge in investment in research and development (R&D) is notable, driven by increased focus on the pharmaceutical industry, especially during the pandemic.

As the world enters the third year of the pandemic, the heightened investment in science has enriched the pipeline, leading to the initiation of numerous clinical trials. Throughout the pandemic, there has been a steady growth in activity related to interventional studies. The pharmaceutical industry has adapted to new ways of conducting trials to manage ongoing clinical research effectively during the pandemic.

The global competition in the market is heating up due to the emergence of small- and medium-scale central laboratories, a trend particularly pronounced in developing regions. These laboratories are assuming a crucial role in the worldwide administration of clinical trials, offering central laboratory services at significantly reduced costs-20% to 35% lower compared to rates in Europe & the U.S. Moreover, the cost-effectiveness of conducting clinical trials in developing economies makes central laboratories in these regions more attractive, with lower logistics costs and proximity to trial locations contributing to their appeal.

The pandemic has escorted in new growth opportunities, particularly with a heightened emphasis on the development of mRNA vaccines and investigations into various treatment options for COVID-19. However, the effective handling of samples, along with managing the supply chain and logistics, is crucial in the context of samples sent to clinical labs. These samples, often associated with COVID-19 testing and research, are highly sensitive. Ensuring swift and efficient logistics is essential, especially with the implementation of temperature control measures. Maintaining the stability of these samples throughout transportation is critical to obtain accurate and reliable results in laboratory analyses. The intricacies of sample handling and logistics underscore the importance of a well-organized and responsive system to support research and diagnostic efforts related to the pandemic.

Central Lab Market Report Highlights

Genetic services segment will grow rapidly, owing to rising cases of genetic inheritance, and use in many clinical studies

Pharmaceutical companies held the largest share, primarily due to rise in number of clinical trials

North America dominated the market, on account of rise in personalized treatment in the developed economies

The key market players include ACM Global Laboratories, Labconnect, Cerba Research, Medicover Integrated Clinical Services, Versiti, & Cirion Biopharma

Polaris Market Research has segmented the central lab market report based on services, end use, and region:

Central Lab, Services Outlook (Revenue - USD Billion, 2019 - 2032)

  • Genetic Services
  • Biomarker Services
  • Microbiology Services
  • Anatomic Pathology/Histology
  • Specimen Management & Storage
  • Special Chemistry Services
  • Others

Central Lab, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes

Central Lab, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Central Lab Market Insights

  • 4.1. Central Lab Market - Industry Snapshot
  • 4.2. Central Lab Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Clinical Trials
      • 4.2.1.2. Rising Prevalence of Chronic Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Central Lab Services
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Central Lab Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Central Lab Market, by Services

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Central Lab, by Services, 2019-2032 (USD Billion)
  • 5.3. Genetic Services
    • 5.3.1. Global Central Lab Market, by Genetic Services, by Region, 2019-2032 (USD Billion)
  • 5.4. Biomarker Services
    • 5.4.1. Global Central Lab Market, by Biomarker Services, by Region, 2019-2032 (USD Billion)
  • 5.5. Services 3Microbiology Services
    • 5.5.1. Global Central Lab Market, by Microbiology Services, by Region, 2019-2032 (USD Billion)
  • 5.6. Anatomic Pathology/Histology
    • 5.6.1. Global Central Lab Market, by Anatomic Pathology/Histology, by Region, 2019-2032 (USD Billion)
  • 5.7. Specimen Management & Storage
    • 5.7.1. Global Central Lab Market, by Specimen Management & Storage, by Region, 2019-2032 (USD Billion)
  • 5.8. Special Chemistry Services
    • 5.8.1. Global Central Lab Market, by Special Chemistry Services, by Region, 2019-2032 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Central Lab Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Central Lab Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Central Lab Market, by End Use, 2019-2032 (USD Billion)
  • 6.3. Pharmaceutical Companies
    • 6.3.1. Global Central Lab Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
  • 6.4. Biotechnology Companies
    • 6.4.1. Global Central Lab Market, by Biotechnology Companies, by Region, 2019-2032 (USD Billion)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Global Central Lab Market, by Academic & Research Institutes, by Region, 2019-2032 (USD Billion)

7. Global Central Lab Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Central Lab Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Central Lab Market - North America
    • 7.3.1. North America: Central Lab Market, by End Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.3.3. Central Lab Market - U.S.
      • 7.3.3.1. U.S.: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.3.4. Central Lab Market - Canada
      • 7.3.4.1. Canada: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • 7.4. Central Lab Market - Europe
    • 7.4.1. Europe: Central Lab Market, by End Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.3. Central Lab Market - UK
      • 7.4.3.1. UK: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.4. Central Lab Market - France
      • 7.4.4.1. France: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.5. Central Lab Market - Germany
      • 7.4.5.1. Germany: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.6. Central Lab Market - Italy
      • 7.4.6.1. Italy: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.7. Central Lab Market - Spain
      • 7.4.7.1. Spain: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.8. Central Lab Market - Netherlands
      • 7.4.8.1. Netherlands: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.4.9. Central Lab Market - Russia
      • 7.4.9.1. Russia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • 7.5. Central Lab Market - Asia Pacific
    • 7.5.1. Asia Pacific: Central Lab Market, by End Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.5.3. Central Lab Market - China
      • 7.5.3.1. China: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.5.4. Central Lab Market - India
      • 7.5.4.1. India: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.5.5. Central Lab Market - Malaysia
      • 7.5.5.1. Malaysia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.5.6. Central Lab Market - Japan
      • 7.5.6.1. Japan: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.5.7. Central Lab Market - Indonesia
      • 7.5.7.1. Indonesia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.5.8. Central Lab Market - South Korea
      • 7.5.8.1. South Korea: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • 7.6. Central Lab Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Central Lab Market, by End Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.6.3. Central Lab Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.6.4. Central Lab Market - UAE
      • 7.6.4.1. UAE: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.6.5. Central Lab Market - Israel
      • 7.6.5.1. Israel: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.6.6. Central Lab Market - South Africa
      • 7.6.6.1. South Africa: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Central Lab Market, by Services, 2019-2032 (USD Billion)
  • 7.7. Central Lab Market - Latin America
    • 7.7.1. Latin America: Central Lab Market, by End Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.7.3. Central Lab Market - Mexico
      • 7.7.3.1. Mexico: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.7.4. Central Lab Market - Brazil
      • 7.7.4.1. Brazil: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Central Lab Market, by Services, 2019-2032 (USD Billion)
    • 7.7.5. Central Lab Market - Argentina
      • 7.7.5.1. Argentina: Central Lab Market, by End Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Central Lab Market, by Services, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. ACM Global Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Labconnect
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cerba Research
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Eurofins Scientific
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Versiti (Cenetron)
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. A.P. Moller Holding A/S (Unilabs)
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Ampersand Capital Partners (Pacific Biomarkers)
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Lambda Therapeutics Research Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Cirion Biopharma Research Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development